Prices of 108 diabetes, cardiac formulations fixed: NPPA

The drugs that will become cheaper would include atorvastatin, gliclazide, glimepiride, heparin and metolazone among others.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news